Oxidized Phospholipids and Calcific Aortic Valvular Disease

By sjmartinez • November 16, 2024

Bhatia HS, Dweck MR, Craig N, Capoulade R, Pibarot P, Trainor PJ, Whelton SP, Rikhi R, Lidani KCF, Post WS, Tsai MY, Criqui MH, Shapiro MD, Budoff MJ, DeFilippis AP, Thanassoulis G, Tsimikas S. Oxidized Phospholipids and Calcific Aortic Valvular Disease. J Am Coll Cardiol. 2024 Oct 22:S0735-1097(24)08460-2. doi: 10.1016/j.jacc.2024.08.070. Epub ahead of print. PMID: 39545902.

Tags: aortic valve, Calcification, Cardiology/Epi, Computed tomography, Harbor UCLA, lipoprotein(a), Oxidized phospholipids, Publications, subclinical atherosclerosis

Novel Virtual Reality Intervention for Stress Reduction Among Patients With or at Risk for Cardiovascular Disease: Mixed Methods Pilot Study

Makaroff KE, Van C, Grospe V, Edmunds L, Calfon-Press MA, Watson KE, Horwich T. Novel Virtual Reality Intervention for Stress Reduction Among Patients With or[...]

Association of hematological malignancies with clinical and financial outcomes following transcatheter aortic valve replacement

Liu Z, Aguayo E, Porter G, Ali K, Zinoviev R, Benharash P. Association of hematological malignancies with clinical and financial outcomes following transcatheter aortic valve[...]

Design and rationale of a randomized clinical trial assessing the effect of inclisiran on atherosclerotic plaque in individuals without previous cardiovascular event and without flow- limiting lesions identified in an in-hospital screening – The VICTORION-PLAQUE primary prevention trial

Revaiah PC, Serruys PW, Onuma Y, Andreini D, Budoff MJ, Sharif F, Chernofsky A, Vikarunnessa S, Wiethoff AJ, Yates D, Achouba A. Design and rationale[...]